Evidence map›Paper›PMID 26075393›Full record

ArticlePloS one2015

Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000-2012.

Guadalupe Delgado-Sánchez, Lourdes García-García, Martín Castellanos-Joya, Pablo Cruz-Hervert, Leticia Ferreyra-Reyes, Elizabeth Ferreira-Guerrero, Andrés Hernández, Victor Manuel Ortega-Baeza, Rogelio Montero-Campos, José Antonio Sulca and 8 more

Registry-linked trialAbstract readHistorical Article
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03277742 (Evaluation of an Integral Strategy for Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz.), which is not on this map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03277742 nawithdrawnnot on this mapstarted 2017, after this paper: background citation

Evaluation of an Integral Strategy for Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz.

TypeinterventionalSponsorInstituto Nacional de Salud Publica, MexicoRan2017 to 2020Enrolled0ConditionsPulmonary Tuberculosis, Diabetes Mellitus, Type 2ArmsCommunity intervention, Standard of care
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Molecular Epidemiology ofMicroorganisms · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Diabetic lung disease: fact or fiction?Reviews in endocrine & metabolic disorders · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Guadalupe Delgado-SánchezCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Lourdes García-GarcíaCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Martín Castellanos-JoyaDirección de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Pablo Cruz-HervertCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Leticia Ferreyra-ReyesCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Elizabeth Ferreira-GuerreroCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Andrés HernándezDepartamento de Epidemiología, Instituto Nacional de Enfermedades Respiratorias, México, Distrito Federal, México.
Victor Manuel Ortega-BaezaCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Rogelio Montero-CamposCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
José Antonio SulcaDirección de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Ma de Lourdes Martínez-OlivaresDirección de Micobacteriosis, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Norma Mongua-RodríguezCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Renata Baez-SaldañaCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Jesús Felipe González-RoldánDirección General, Centro Nacional de Programas Preventivos y Control de Enfermedades, México, Distrito Federal, México.
Hugo López-GatellCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Alfredo Ponce-de-LeónLaboratorio de Microbiología, Instituto Nacional de Ciencias Médicas y de Nutrición "Salvador Zubirán", México, Distrito Federal, México.
José Sifuentes-OsornioDirección Médica, Instituto Nacional de Ciencias Médicas y de Nutrición "Salvador Zubirán", México, Distrito Federal, México.
María Eugenia Jiménez-CoronaDirección General Adjunta de Epidemiología, Dirección General de Epidemiología, México, Distrito Federal, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) remains a public health problem in Mexico while the incidence of diabetes mellitus type 2 (DM) has increased rapidly in recent years.

objectiveTo describe the trends of incidence rates of pulmonary TB associated with DM and not associated with DM and to compare the results of treatment outcomes in patients with and without DM. MATERIALS AND

methodsWe analysed the National Tuberculosis Registry from 2000 to 2012 including patients with pulmonary TB among individuals older than 20 years of age. The association between DM and treatment failure was analysed using logistic regression, accounting for clustering due to regional distribution.

resultsIn Mexico from 2000 to 2012, the incidence rates of pulmonary TB associated to DM increased by 82.64%, (p<0.001) in contrast to rates of pulmonary TB rate without DM, which decreased by 26.77%, (p<0.001). Patients with a prior diagnosis of DM had a greater likelihood of failing treatment (adjusted odds ratio, 1.34 (1.11-1.61) p<0.002) compared with patients who did not have DM. There was statistical evidence of interaction between DM and sex. The odds of treatment failure were increased in both sexes.

conclusionOur data suggest that the growing DM epidemic has an impact on the rates of pulmonary TB. In addition, patients who suffer from both diseases have a greater probability of treatment failure.

Indexed as

AdultAgedDiabetes Mellitus, Type 2FemaleHistory, 21st CenturyHumansIncidenceMaleMexicoMiddle AgedOdds RatioPublic Health SurveillanceRegistriesTreatment FailureTreatment OutcomeTuberculosis, Pulmonary

Identifiers

PMID26075393
PMCPMC4468212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.